Findings of Scientific Misconduct, 3973 [E8-1024]

Download as PDF Federal Register / Vol. 73, No. 15 / Wednesday, January 23, 2008 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institute for Occupational Safety and Health Office of the Secretary Findings of Scientific Misconduct Final Effect of Designation of a Class of Employees for Addition to the Special Exposure Cohort National Institute for Occupational Safety and Health (NIOSH), Department of Health and Human Services (HHS). AGENCY: ACTION: Notice. SUMMARY: The Department of Health and Human Services (HHS) gives notice concerning the final effect of the HHS decision to designate a class of employees at Nuclear Materials and Equipment Corporation (NUMEC) in Apollo, Pennsylvania, as an addition to the Special Exposure Cohort (SEC) under the Energy Employees Occupational Illness Compensation Program Act of 2000. On November 29, 2007, as provided for under 42 U.S.C. 7384q(b), the Secretary of HHS designated the following class of employees as an addition to the SEC: Atomic Weapons Employer (AWE) employees who were monitored or should have been monitored for exposure to ionizing radiation while working at the Nuclear Materials and Equipment Corporation (NUMEC) in Apollo, Pennsylvania from January 1, 1957, through December 31, 1983, for a number of work days aggregating at least 250 work days or in combination with work days within the parameters established for one or more other classes of employees in the Special Exposure Cohort. This designation became effective on December 29, 2007, as provided for under 42 U.S.C. 7384l(14)(C). Hence, beginning on December 29, 2007, members of this class of employees, defined as reported in this notice, became members of the Special Exposure Cohort. FOR FURTHER INFORMATION CONTACT: ebenthall on PROD1PC69 with NOTICES Larry Elliott, Director, Office of Compensation Analysis and Support, National Institute for Occupational Safety and Health, 4676 Columbia Parkway, MS C–46, Cincinnati, OH 45226, Telephone 513–533–6800 (this is not a toll-free number). Information requests can also be submitted by e-mail to OCAS@CDC.GOV. Dated: January 15, 2008. John Howard, Director, National Institute for Occupational Safety and Health. [FR Doc. E8–1018 Filed 1–22–08; 8:45 am] BILLING CODE 4160–17–P VerDate Aug<31>2005 15:17 Jan 22, 2008 Jkt 214001 Office of the Secretary, HHS. Notice. AGENCY: ACTION: SUMMARY: Notice is hereby given that the Office of Research Integrity (ORI) and the Assistant Secretary for Health have taken final action in the following case: Scott E. Monte, Huntington Memorial Hospital: Based on the findings of an investigation conducted by Huntington Memorial Hospital (HMH) and information obtained by the Office of Research Integrity (ORI) during its oversight review, the U.S. Public Health Service (PHS) found that Scott E. Monte, L.V.N., former Clinical Research Associate, HMH, engaged in scientific misconduct by knowingly and intentionally falsifying and fabricating clinical research records in HMH cancer prevention and treatment protocols supported by National Cancer Institute (NCI), National Institutes of Health (NIH), awards U10 CA69651, U10 CA12027, U10 CA32012, and U10 CA86004. Specifically, Mr. Monte knowingly and intentionally: (1) Entered falsified and fabricated laboratory data or physical examination results on five (5) research protocol case report forms (CRFs); (2) Falsified a gynecological examination report in a physician’s progress note and entered the falsified document in the patient’s research chart; and (3) Fabricated progress notes for four patients and a case report form for one of these patients. ORI has implemented the following administrative actions for a period of three (3) years, beginning on January 7, 2008: (1) Dr. Monte is debarred from any contracting or subcontracting with any agency of the United States Government and from eligibility or involvement in nonprocurement programs of the United States Government pursuant to HHS’ implementation of the OMB Guidelines to Agencies on Governmentwide Debarment and Suspension at 2 CFR Part 376; and (2) Dr. Monte is prohibited from serving in any advisory capacity to PHS, including but not limited to service on any PHS advisory committee, board, and/or peer review committee, or as a consultant. FOR FURTHER INFORMATION CONTACT: Director, Division of Investigative PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 3973 Oversight, Office of Research Integrity, 1101 Wootton Parkway, Suite 750, Rockville, MD 20852, (240) 453–8800. Chris B. Pascal, Director, Office of Research Integrity. [FR Doc. E8–1024 Filed 1–22–08; 8:45 am] BILLING CODE 4150–31–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the National Coordinator for Health Information Technology (ONC), DHHS Notice of Availability: Secretarial Recognition of Certain Healthcare Information Technology Standards Panel (HITSP) Interoperability Specifications as Interoperability Standards for Health Information Technology Office of the National Coordinator for Health Information Technology (ONC), DHHS. Authority: Executive Order 13335 (‘‘Incentives for the Use of Health Information Technology and Establishing the Position of the National Health Information Technology Coordinator’’), Executive Order 13410 (‘‘Promoting Quality and Efficient Health Care in Federal Government Administered or Sponsored Health Care Programs’’), Public Law 110–161, (‘‘Consolidated Appropriations Act, 2008’’), 42 U.S.C.1395nn(b)(4), 42 U.S.C. 1302(a), and 42 CFR 411.357(w). SUMMARY: By publication of this document, we are informing the public of the Secretary’s recognition of certain Healthcare Information Technology Standards Panel (HITSP) ‘‘Interoperability Specifications’’ as interoperability standards for health information technology. The Secretary accepted these HITSP ‘‘Interoperability Specifications’’, Version 1.2, in December of 2006, and hereby recognizes them as interoperability standards in updated versions in January of 2008. The list of recognized interoperability standards is provided below and is available at https:// www.hitsp.org; click on ‘‘HITSP Interoperability Specifications HERE’’ box. AGENCY: The Healthcare Information Technology Standards Panel (HITSP) was created in 2005 to serve as a cooperative partnership between the public and private sectors for the purpose of achieving a widely accepted and useful set of standards specifically to enable and support widespread interoperability SUPPLEMENTARY INFORMATION: E:\FR\FM\23JAN1.SGM 23JAN1

Agencies

[Federal Register Volume 73, Number 15 (Wednesday, January 23, 2008)]
[Notices]
[Page 3973]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-1024]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


Findings of Scientific Misconduct

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the Office of Research Integrity 
(ORI) and the Assistant Secretary for Health have taken final action in 
the following case:
    Scott E. Monte, Huntington Memorial Hospital: Based on the findings 
of an investigation conducted by Huntington Memorial Hospital (HMH) and 
information obtained by the Office of Research Integrity (ORI) during 
its oversight review, the U.S. Public Health Service (PHS) found that 
Scott E. Monte, L.V.N., former Clinical Research Associate, HMH, 
engaged in scientific misconduct by knowingly and intentionally 
falsifying and fabricating clinical research records in HMH cancer 
prevention and treatment protocols supported by National Cancer 
Institute (NCI), National Institutes of Health (NIH), awards U10 
CA69651, U10 CA12027, U10 CA32012, and U10 CA86004.
    Specifically, Mr. Monte knowingly and intentionally:
    (1) Entered falsified and fabricated laboratory data or physical 
examination results on five (5) research protocol case report forms 
(CRFs);
    (2) Falsified a gynecological examination report in a physician's 
progress note and entered the falsified document in the patient's 
research chart; and
    (3) Fabricated progress notes for four patients and a case report 
form for one of these patients.
    ORI has implemented the following administrative actions for a 
period of three (3) years, beginning on January 7, 2008:
    (1) Dr. Monte is debarred from any contracting or subcontracting 
with any agency of the United States Government and from eligibility or 
involvement in nonprocurement programs of the United States Government 
pursuant to HHS' implementation of the OMB Guidelines to Agencies on 
Governmentwide Debarment and Suspension at 2 CFR Part 376; and
    (2) Dr. Monte is prohibited from serving in any advisory capacity 
to PHS, including but not limited to service on any PHS advisory 
committee, board, and/or peer review committee, or as a consultant.

FOR FURTHER INFORMATION CONTACT: Director, Division of Investigative 
Oversight, Office of Research Integrity, 1101 Wootton Parkway, Suite 
750, Rockville, MD 20852, (240) 453-8800.

Chris B. Pascal,
Director, Office of Research Integrity.
 [FR Doc. E8-1024 Filed 1-22-08; 8:45 am]
BILLING CODE 4150-31-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.